Page last updated: 2024-08-24

isobutyramide and Anemia, Sickle Cell

isobutyramide has been researched along with Anemia, Sickle Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dover, GJ; Faller, DV; Ginder, GD; Olivieri, NF; Perrine, SP; Vichinsky, EP1
Daftari, P; Dover, GH; Faller, DV; Jin, Y; Mays, A; Perrine, SP; Walsh, CT1
Gu, LH; Huisman, TH; Jansen, R; Saleh, AW; van Goethem, A; Velvis, HJ1

Trials

1 trial(s) available for isobutyramide and Anemia, Sickle Cell

ArticleYear
Isobutyramide therapy in patients with sickle cell anemia.
    American journal of hematology, 1995, Volume: 49, Issue:3

    Topics: Adult; Amides; Anemia, Sickle Cell; Female; Fetal Hemoglobin; Globins; Humans; Hydroxyurea; L-Lactate Dehydrogenase; Male; Middle Aged

1995

Other Studies

2 other study(ies) available for isobutyramide and Anemia, Sickle Cell

ArticleYear
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
    The American journal of pediatric hematology/oncology, 1994, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Amides; Anemia, Sickle Cell; Animals; Arginine; beta-Thalassemia; Butyrates; Child; Child, Preschool; Fetal Hemoglobin; Globins; Humans; Promoter Regions, Genetic

1994
Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo.
    British journal of haematology, 1994, Volume: 88, Issue:3

    Topics: Administration, Oral; Amides; Anemia, Sickle Cell; Animals; beta-Thalassemia; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Genes, Reporter; Globins; Humans; Male; Papio; Promoter Regions, Genetic; Transfection

1994